LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Clinical-stage Biopharma Y-mAbs Therapeutics is a commercial-stage clinical biopharmaceutical company specializing in novel antibody-based therapeutic products for cancer treatment, making it a potential sales target for pharmaceutical partnerships and collaborations.

Advanced Product Pipeline With a diverse and advanced product pipeline that includes pivotal-stage product candidates, Y-mAbs offers opportunities for licensing agreements or joint ventures with companies looking to expand their oncology product portfolios.

Key Personnel Appointments Recent strategic appointments of key personnel like the Chief Financial Officer, Chief Development Officer, and Board of Directors members indicate a strengthened leadership team, potentially opening avenues for strategic partnerships and vendor relationships.

FDA-Approved Products Y-mAbs' development of cancer-fighting antibodies, including the FDA-approved Danyelza for high-risk neuroblastoma patients, positions the company as a potential collaborator for distribution or marketing partnerships in the oncology space.

Solid Financial Standing With revenues ranging from $10M to $50M and significant funding of $115M, Y-mAbs Therapeutics demonstrates financial stability, which can attract investors or companies seeking investment opportunities in the biotechnology sector.

Similar companies to Y-mAbs Therapeutics, Inc.

✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Y-mAbs Therapeutics, Inc. Tech Stack

Y-mAbs Therapeutics, Inc. uses 8 technology products and services including Akamai, Cloudflare CDN, WordPress, and more. Explore Y-mAbs Therapeutics, Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • Shopify
    E-commerce
  • React
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • Module Federation
    Miscellaneous
  • HSTS
    Security

Media & News

Y-mAbs Therapeutics, Inc.'s Email Address Formats

Y-mAbs Therapeutics, Inc. uses at least 1 format(s):
Y-mAbs Therapeutics, Inc. Email FormatsExamplePercentage
FL@ymabs.comJD@ymabs.com
36%
FLast@ymabs.comJDoe@ymabs.com
29%
FirstLast@ymabs.comJohnDoe@ymabs.com
21%
Last@ymabs.comDoe@ymabs.com
14%

Frequently Asked Questions

Where is Y-mAbs Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc.'s main headquarters is located at 230 Park Avenue 3350 New York, NY 10169 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Y-mAbs Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Y-mAbs Therapeutics, Inc.'s main corporate office by phone at
✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-646-885-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Y-mAbs Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc. is a publicly traded company; the company's stock symbol is YMAB.

What is Y-mAbs Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc.'s official website is ymabs.com and has social profiles on LinkedIn.

How much revenue does Y-mAbs Therapeutics, Inc. generate?

Minus sign iconPlus sign icon As of September 2024, Y-mAbs Therapeutics, Inc.'s annual revenue reached $35M.

What is Y-mAbs Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Y-mAbs Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of September 2024, Y-mAbs Therapeutics, Inc. has approximately 120 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Vice President Commercial Sales: H. M.Vice President Market Access: C. B.Head Of Medical Affairs, Vice President: A. M.. Explore Y-mAbs Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Y-mAbs Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Y-mAbs Therapeutics, Inc. use?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc.'s tech stack includes AkamaiCloudflare CDNWordPressShopifyReactOpen GraphModule FederationHSTS.

What is Y-mAbs Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc.'s email format typically follows the pattern of . Find more Y-mAbs Therapeutics, Inc. email formats with LeadIQ.

How much funding has Y-mAbs Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of September 2024, Y-mAbs Therapeutics, Inc. has raised $115M in funding. The last funding round occurred on Feb 17, 2021 for $115M.

When was Y-mAbs Therapeutics, Inc. founded?

Minus sign iconPlus sign iconY-mAbs Therapeutics, Inc. was founded in 2015.
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets.

Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.

✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
230 Park Avenue 3350 New York, NY 10169 US
Phone number
✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-646-885-****
Website
ymabs.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
YMAB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $115M

    Y-mAbs Therapeutics, Inc. has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Feb 17, 2021 in the amount of $115M.

  • $10M$50M

    Y-mAbs Therapeutics, Inc.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Y-mAbs Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Y-mAbs Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.